# CEFAZOLIN SODIUM
> **NDA211413** · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2023-05-08
## Drug
- **FDA Application Number:** NDA211413
- **Application type:** New Drug Application
- **Brand name:** CEFAZOLIN SODIUM
- **Generic name:** CEFAZOLIN
- **Active ingredients:** CEFAZOLIN SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** HQ SPCLT PHARMA
- **Manufacturer:** WG Critical Care, LLC
- **First approval:** 2023-05-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211413)
---
*AI Analytics · CC0 1.0*